Details for Patent: 10,398,785
✉ Email this page to a colleague
Which drugs does patent 10,398,785 protect, and when does it expire?
Patent 10,398,785 protects DOCIVYX and is included in one NDA.
This patent has eight patent family members in five countries.
Drugs Protected by US Patent 10,398,785
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avyxa Holdings | DOCIVYX | docetaxel | SOLUTION;INTRAVENOUS | 215813-001 | Nov 22, 2022 | RX | Yes | Yes | 10,398,785 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Avyxa Holdings | DOCIVYX | docetaxel | SOLUTION;INTRAVENOUS | 215813-002 | Nov 22, 2022 | RX | Yes | Yes | 10,398,785 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Avyxa Holdings | DOCIVYX | docetaxel | SOLUTION;INTRAVENOUS | 215813-003 | Nov 22, 2022 | RX | Yes | Yes | 10,398,785 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,398,785
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| China | 107427486 | ⤷ Subscribe | |||
| China | 111714449 | ⤷ Subscribe | |||
| China | 111728940 | ⤷ Subscribe | |||
| China | 111728941 | ⤷ Subscribe | |||
| European Patent Office | 3270912 | ⤷ Subscribe | |||
| Japan | 2018512395 | ⤷ Subscribe | |||
| Poland | 3270912 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
